Cross-Cultural Validation of the RECAP of Atopic Eczema Question­naire in a Swedish Population

Authors

  • Gunnthorunn Sigurdardottir Department of Dermatology and Venereology in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
  • Mikael Alsterholm Department of Dermatology and Venereology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
  • Chris D. Andersson Department of Dermatology and Venereology in Östergötland, and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden
  • Maria Bradley Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Dermatology, Karolinska University Hospital, Stockholm, Sweden
  • MariHelen Sandström Falk Vasakliniken Dermatology Clinic, Gothenburg, Sweden
  • Emma K. Johansson Division of Dermatology and Venereology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Dermatology, Karolinska University Hospital, Stockholm, Sweden
  • Maria Lundqvist Dermatology, Karolinska University Hospital, Stockholm, Sweden
  • Andreas Sonesson Department of Dermatology and Venereology, Skåne University Hospital, Lund, Sweden; Division of Dermatology and Venereology, Department of Clinical Sciences, Lund University, Lund, Sweden
  • Åke Svensson Department of Dermatology and Venereology, Skåne University Hospital, Lund, Sweden; Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden
  • Grigorios Theodosiou Department of Dermatology and Venereology, Skåne University Hospital, Malmö, Sweden
  • Sophie Vrang Patients’ organisation Atopikerna, The Swedish Asthma and Allergy Association, Stockholm, Sweden
  • Laura B. von Kobyletzki Department of Occupational and Environmental Dermatology, Lund University, Skåne University Hospital, Malmö, Sweden; School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

DOI:

https://doi.org/10.2340/actadv.v104.38889

Keywords:

atopic dermatitis, eczema, patient-reported outcome measure, validation study

Abstract

A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic dermatitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-ADTM). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (interquartile range [IQR] 27–48). The participants considered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0–28) was 12 (IQR 5–19). The mean and median vIGA-ADTM scores (range 0–4) were 2 (standard deviation [SD] 2) and 3 (IQR 2–4), respectively. A correlation between RECAP and the vIGA-ADTM was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluat-ed by vIGA-ADTM, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows -acceptable reliability.

Downloads

Download data is not yet available.

References

Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy 2015; 70: 836-845.

https://doi.org/10.1111/all.12619 DOI: https://doi.org/10.1111/all.12619

Bylund S, Kobyletzki LB, Svalstedt M, Svensson A. Prevalence and incidence of atopic dermatitis: a systematic review. Acta Derm Venereol 2020; 100: adv00160.

https://doi.org/10.2340/00015555-3510 DOI: https://doi.org/10.2340/00015555-3510

Hadi HA, Tarmizi AI, Khalid KA, Gajdacs M, Aslam A, Jamshed S. The epidemiology and global burden of atopic dermatitis: a narrative review. Life (Basel) 2021; 11: 936.

https://doi.org/10.3390/life11090936 DOI: https://doi.org/10.3390/life11090936

Williams HC, Schmitt J, Thomas KS, Spuls PI, Simpson EL, Apfelbacher CJ, et al. The HOME Core outcome set for clinical trials of atopic dermatitis. J Allergy Clin Immunol 2022; 149: 1899-1911.

https://doi.org/10.1016/j.jaci.2022.03.017 DOI: https://doi.org/10.1016/j.jaci.2022.03.017

Howells LM, Chalmers JR, Gran S, Ahmed A, Apfelbacher C, Burton T, et al. Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP). Br J Dermatol 2020; 183: 524-536.

https://doi.org/10.1111/bjd.18780 DOI: https://doi.org/10.1111/bjd.18780

Leshem YA, Chalmers JR, Apfelbacher C, Katoh N, Gerbens LAA, Schmitt J, et al. Measuring atopic eczema control and itch intensity in clinical practice: a consensus statement from the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) initiative. JAMA Dermatol 2022; 158: 1429-1435.

https://doi.org/10.1001/jamadermatol.2022.4211 DOI: https://doi.org/10.1001/jamadermatol.2022.4211

Bhanot A, Peters TJ, Ridd MJ. Assessing the validity, responsiveness and reliability of the Recap measure of eczema control. Br J Dermatol 2021; 184: 955-957.

https://doi.org/10.1111/bjd.19709 DOI: https://doi.org/10.1111/bjd.19709

Bhanot A, Vincent R, Peters TJ, Ridd MJ. Validation of the RECap of AtoPic eczema measure of eczema control for use in dermatology clinics. Clin Exp Dermatol 2022; 47: 440-442.

https://doi.org/10.1111/ced.14934 DOI: https://doi.org/10.1111/ced.14934

Simpson E, Bissonnette R, Eichenfield LF, Guttman-Yassky E, King B, Silverberg JI, et al. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): the development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis. J Am Acad Dermatol 2020; 83: 839-846.

https://doi.org/10.1016/j.jaad.2020.04.104 DOI: https://doi.org/10.1016/j.jaad.2020.04.104

University of Nottingham CoEBD. RECAP translations. Available from: https://www.nottingham.ac.uk/research/groups/cebd/resources/recap.aspx, 2023.

Gabes M, Tischer C, Herrmann A, Howells L, Apfelbacher C. The German RECAP questionnaire: linguistic validation and cognitive debriefing in German adults with self-reported atopic eczema and parents of affected children. J Patient Rep Outcomes 2021; 5: 13.

https://doi.org/10.1186/s41687-021-00285-2 DOI: https://doi.org/10.1186/s41687-021-00285-2

Onteniente-Gomis MM, Ortiz-Romero PL, Tous Romero F, Salamanca Castro AB, Ortiz de Frutos FJ. Spanish version of the RECAP questionnaire to assess control of atopic eczema: translation, cultural adaptation, validation, and correlations with other patient-reported outcome measures. Actas Dermosifiliogr 2023; 114: 488-493. DOI: https://doi.org/10.1016/j.ad.2023.05.009

https://doi.org/10.1016/j.ad.2023.02.018 DOI: https://doi.org/10.1016/j.ad.2023.02.018

Gabes M, Ragamin A, Baker A, Kann G, Donhauser T, Gabes D, et al. Content validity of the Recap of atopic eczema (RECAP) instrument in Dutch, English and German to measure eczema control in young people with atopic eczema: a cognitive interview study. Br J Dermatol 2022; 187: 919-926.

https://doi.org/10.1111/bjd.21767 DOI: https://doi.org/10.1111/bjd.21767

Simpson EL, Bissonnette R, Paller AS, King B, Silverberg JI, Reich K, et al. The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): a clinical outcome measure for the severity of atopic dermatitis. Br J Dermatol 2022; 187: 531-538.

https://doi.org/10.1111/bjd.21615 DOI: https://doi.org/10.1111/bjd.21615

Zhang J, Ragamin A, Romeijn GLE, Loman L, Oosterhaven JAF, Schuttelaar MLA. Validity, reliability, responsiveness and interpretability of the Recap of atopic eczema (RECAP) questionnaire. Br J Dermatol 2023; 189: 578-587.

https://doi.org/10.1093/bjd/ljad247 DOI: https://doi.org/10.1093/bjd/ljad247

Downloads

Published

2024-06-19

How to Cite

Sigurdardottir, G., Alsterholm, M., Andersson, C. D., Bradley, M. ., Sandström Falk, M., Johansson, E. K., … von Kobyletzki, L. B. (2024). Cross-Cultural Validation of the RECAP of Atopic Eczema Question­naire in a Swedish Population. Acta Dermato-Venereologica, 104, adv38889. https://doi.org/10.2340/actadv.v104.38889

Issue

Vol. 104 (2024)

Section

Articles

Categories

License

Copyright (c) 2024 Gunnthorunn Sigurdardottir, Mikael Alsterholm, Chris D. Andersson, Maria Bradley, MariHelen Sandström Falk, Emma K. Johansson, Maria Lundqvist, Andreas Sonesson, Åke Svensson, Grigorios Theodosiou , Sophie Vrang, Laura B. von Kobyletzki

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC